EPO and obesity due to melanocortin 4 receptor deficiency: The increased EPO levels observed in obesity could suggest that EPO is secreted to counteract the metabolic deficiencies in these patients with a variable degree of systemic inflammation related with an increase in adipose tissue and cytokine production [14, 33, 34].